Clinical Trial Update: Etanercept (Enbrel) in Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating etanercept (Enbrel) for ankylosing spondylitis, sponsored by Charité University Berlin; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Etanercept (Enbrel) (Etanercept)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Ankylosing Spondylitis | Phase 2 | Status: UNKNOWN